PT Tempo Scan Pacific Tbk (ISX:TSPC) 3-Year EBITDA Growth Rate : 13.10% (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is PT Tempo Scan Pacific Tbk 3-Year EBITDA Growth Rate?

PT Tempo Scan Pacific Tbk's EBITDA per Share for the three months ended in Mar. 2024 was Rp140.38.

During the past 12 months, PT Tempo Scan Pacific Tbk's average EBITDA Per Share Growth Rate was -10.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Tempo Scan Pacific Tbk was 27.30% per year. The lowest was -2.50% per year. And the median was 12.75% per year.

Competitive Comparison of PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate falls into.

PT Tempo Scan Pacific Tbk 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PT Tempo Scan Pacific Tbk (ISX:TSPC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PT Tempo Scan Pacific Tbk 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Tempo Scan Pacific Tbk (ISX:TSPC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Tempo Scan Pacific Tbk (ISX:TSPC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan H.R. Rasuna Said Kav. 3-4, Tempo Scan Tower, 16th Floor, Jakarta, IDN, 12950

Website

https://www.temposcangroup.com

PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms and markets body care products. It operates through the following segments: The Pharmaceuticals segment, Consumer Products and Cosmetics segment, and Distribution Services segment. The company caters to both Indonesian and international markets.

PT Tempo Scan Pacific Tbk (ISX:TSPC) Headlines

No Headlines